EPISODE · Apr 15, 2019 · 7 MIN
CEO Robert Davidson of CURE Pharmaceutical Holding Corp. (OTCQB: CURR) - April '19 update
from Stock Day Media · host Stock Day Media
CEO Robert Davidson of CURE Pharmaceutical Holding Corp. (OTCQB: CURR) returns to the show to talk about licenses granted to them for cannibinoids, working towards precise dosing, and navigating the ever changing regulatory guidelines. clinical studies # CURE Dots # CURE Film # formulating and manufacturing # malaria # medical # oral thin film # pharmaceutical # product testing # sublingual and transdermal applications # veterinarian products Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
CEO Robert Davidson of CURE Pharmaceutical Holding Corp. (OTCQB: CURR) returns to the show to talk about licenses granted to them for cannibinoids, working towards precise dosing, and navigating the ever changing regulatory guidelines. clinical studies # CURE Dots # CURE Film # formulating and manufacturing # malaria # medical # oral thin film # pharmaceutical # product testing # sublingual and transdermal applications # veterinarian products Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
CEO Robert Davidson of CURE Pharmaceutical Holding Corp. (OTCQB: CURR) - April '19 update
No transcript for this episode yet
Similar Episodes
Sep 22, 2023 ·20m
Sep 22, 2023 ·20m
Sep 22, 2023 ·27m
Sep 22, 2023 ·14m
Sep 22, 2023 ·24m
Sep 22, 2023 ·22m